Cornercap Investment Counsel Inc. Has $414,000 Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Cornercap Investment Counsel Inc. trimmed its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 48.2% during the third quarter, Holdings Channel reports. The firm owned 4,454 shares of the medical instruments supplier’s stock after selling 4,143 shares during the quarter. Cornercap Investment Counsel Inc.’s holdings in LeMaitre Vascular were worth $414,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. NBC Securities Inc. lifted its stake in shares of LeMaitre Vascular by 73.2% in the 3rd quarter. NBC Securities Inc. now owns 433 shares of the medical instruments supplier’s stock valued at $40,000 after purchasing an additional 183 shares during the period. GAMMA Investing LLC raised its stake in LeMaitre Vascular by 57.0% during the 2nd quarter. GAMMA Investing LLC now owns 548 shares of the medical instruments supplier’s stock worth $45,000 after buying an additional 199 shares during the period. USA Financial Formulas acquired a new position in LeMaitre Vascular during the 3rd quarter worth approximately $60,000. West Oak Capital LLC acquired a new position in LeMaitre Vascular during the 2nd quarter worth approximately $58,000. Finally, nVerses Capital LLC raised its stake in LeMaitre Vascular by 33.3% during the 2nd quarter. nVerses Capital LLC now owns 800 shares of the medical instruments supplier’s stock worth $66,000 after buying an additional 200 shares during the period. 84.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on LMAT. Oppenheimer reaffirmed an “outperform” rating and set a $93.00 price target (up from $90.00) on shares of LeMaitre Vascular in a research note on Friday, November 1st. Barrington Research upped their price target on LeMaitre Vascular from $92.00 to $93.00 and gave the stock an “outperform” rating in a research note on Friday, November 1st. JMP Securities upped their price target on LeMaitre Vascular from $77.00 to $100.00 and gave the stock a “market outperform” rating in a research note on Tuesday, August 20th. Lake Street Capital initiated coverage on LeMaitre Vascular in a research note on Friday, August 2nd. They set a “buy” rating and a $105.00 price target on the stock. Finally, Cantor Fitzgerald initiated coverage on LeMaitre Vascular in a report on Tuesday, October 15th. They set a “neutral” rating and a $96.00 price objective for the company. Two research analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.57.

LeMaitre Vascular Stock Performance

Shares of LMAT opened at $102.02 on Friday. The firm has a market capitalization of $2.29 billion, a P/E ratio of 55.75, a P/E/G ratio of 2.51 and a beta of 0.89. The stock has a 50 day moving average price of $92.11 and a two-hundred day moving average price of $85.61. LeMaitre Vascular, Inc. has a 52 week low of $51.70 and a 52 week high of $106.49.

LeMaitre Vascular (NASDAQ:LMAT) last released its earnings results on Thursday, October 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.05. The company had revenue of $54.82 million during the quarter, compared to analyst estimates of $53.50 million. LeMaitre Vascular had a return on equity of 13.15% and a net margin of 19.40%. LeMaitre Vascular’s quarterly revenue was up 15.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.33 earnings per share. On average, equities analysts forecast that LeMaitre Vascular, Inc. will post 1.94 earnings per share for the current year.

LeMaitre Vascular Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 5th. Stockholders of record on Thursday, November 21st will be issued a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 0.63%. The ex-dividend date of this dividend is Thursday, November 21st. LeMaitre Vascular’s dividend payout ratio is presently 34.97%.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.